National Institute on Aging; Notice of Closed Meeting, 57832 [2015-24322]
Download as PDF
<![CDATA[
57832
Federal Register / Vol. 80, No. 186 / Friday, September 25, 2015 / Notices
immunization information, smoking
cessation, oral health, as well as
parental depression, domestic violence
and substance use counseling.
Pediatricians would be asked about the
frequency with which they inquire
about, use formal screening instruments,
treat/manage, and refer patients for
various problems/conditions. These
various problems/conditions may
include maternal depression, parental
alcohol/drug use, divorce, illiteracy,
domestic violence exposure, physical or
sexual abuse, neglectful parenting, and
food and housing insecurity. Findings
from the AAP national survey of
pediatricians, in conjunction with
findings from other data sources and
ongoing surveys of home visitors, would
inform MCHB’s understanding of what
is needed to best strengthen the home
visitors’ and pediatricians’
collaborations for at-risk families to
support healthy development and to
Grantee/organization name
Grant number
The American Academy of Pediatrics .......................
U04MC07853 ............................................
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
[FR Doc. 2015–24395 Filed 9–24–15; 8:45 am]
Dated: September 21, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–24322 Filed 9–24–15; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
National Institutes of Health
Name of Committee: National Institute on
Aging Special Emphasis Panel; The Aging
and Memory Project.
Date: October 26, 2015.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Kimberly Firth, Ph.D.,
National Institutes of Health, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
VerDate Sep<11>2014
19:58 Sep 24, 2015
Jkt 235001
Prospective Grant of Start-Up
Exclusive Evaluation Option License
Agreement: Development of
Diagnostic Tests and Kits for Detection
of Pathological Angiogenesis in
Cancer
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of a
Start-Up Exclusive Evaluation Option
License Agreement to Angio360
Diagnostics, LLC, a company having a
place of business in Wauwatosa,
Wisconsin, to practice the inventions
embodied in U.S. Provisional Patent
Application No. 60/858,068, entitled
‘‘Differential Gene Expression in
Physiological and Pathological
Angiogenesis,’’ filed November 9, 2006
(HHS Ref. No.: E–285–2006/0–US–01);
US Provisional Patent Application No.
60/879,457, entitled ‘‘Organ And Tumor
Associated Endothelial Markers,’’ filed
January 8, 2007 (HHS Ref. No. E–285–
2006/1–US–01); PCT Application No.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Lynn Van Pelt, DMD, Division of Child,
Adolescent, and Family Health,
Maternal and Child Health Bureau,
Health Resources and Services
Administration, 5600 Fishers Lane,
Room 18W13B, Rockville, Maryland
20857; lvanpelt@hrsa.gov.
State
Dated: September 21, 2015.
James Macrae,
Acting Administrator.
BILLING CODE 4165–15–P
address the toxic stress and social
determinants that drive health and
developmental disparities for young
children.
FY 2015
authorized
funding level
IL
$1,176,800
FY 2015
estimated
supplemental
funding
$75,000
PCT/US2007/072395, entitled
‘‘Differential Gene Expression in
Physiological and Pathological
Angiogenesis,’’ filed June 8, 2007 (HHS
Ref. No. E–285–2006/2–PCT–01); U.S.
Patent Application No. 12/514,297,
entitled ‘‘Differential Gene Expression
in Physiological and Pathological
Angiogenesis,’’ filed May 8, 2009 (HHS
Ref No. E–285–2006/2–US–02);
Australian Patent No. 2007–317753,
entitled ‘‘Differential Gene Expression
in Physiological and Pathological
Angiogenesis,’’ filed June 28, 2007 (HHS
Ref No. E–285–2006/2–AU–03);
Canadian Patent Application No.
2,669,260, entitled ‘‘Differential Gene
Expression in Physiological and
Pathological Angiogenesis,’’ filed June
28, 2007 (HHS Ref. No. E–285–2006/2–
CA–04); U.S. Patent No.: 8,440,411,
entitled ‘‘Differential Gene Expression
in Physiological and Pathological
Angiogenesis,’’ filed March 21, 2011
(HHS Ref. No. E–285–2006/2–US–05);
U.S. Patent Application No. 13/052,878,
entitled ‘‘Differential Gene Expression
in Physiological and Pathological
Angiogenesis,’’ filed April 16, 2013
(HHS Ref. No.: E–285–2006/2–US–06);
and Australian Application Patent No.:
2014–200453, entitled ‘‘Differential
Gene Expression in Physiological and
Pathological Angiogenesis,’’ filed
January 28, 2014 (HHS Ref No. E–285–
2006/2–AU–07). The patent rights in
these inventions have been assigned to
the Government of the United States of
America. The territory of the
prospective Start-Up Exclusive
Evaluation Option License Agreement
may be worldwide, and the field of use
may be limited to ‘‘Development of
diagnostic tests and kits to determine or
monitor pathological angiogenesis
related to cancer in animals or
humans.’’
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 80, Number 186 (Friday, September 25, 2015)]
[Notices]
[Page 57832]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24322]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; The Aging and Memory Project.
Date: October 26, 2015.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, Suite
2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Kimberly Firth, Ph.D., National Institutes of
Health, National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-402-7702,
firthkm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: September 21, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-24322 Filed 9-24-15; 8:45 am]
BILLING CODE 4140-01-P
